Insider holders · CIK 0001088856
CORCEPT THERAPEUTICS INC · CORT
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Longitude Capital Partners, LLC10% Owner | 10,834,849 | 121,153 | 10,956,002 | Nov 30, 2016 · 9:52 pm EST | Form 4 |
| Longitude Capital Associates, L.P.10% Owner | 10,834,849 | 121,153 | 10,956,002 | Nov 30, 2016 · 9:52 pm EST | Form 4 |
| Longitude Venture Partners L.P.10% Owner | 10,834,849 | 121,153 | 10,956,002 | Nov 30, 2016 · 9:52 pm EST | Form 4 |
| Joseph C Cook Jr.Director | 2,243,723 | 356,568 | 2,600,291 | Mar 25, 2015 · 8:34 pm EDT | Form 4 |
| Joseph K BelanoffChief Executive Officer | 2,164,195 | — | 2,164,195 | Feb 12, 2019 · 9:41 pm EST | Form 4/A |
| G Leonard Baker Jr.Director | 996,838 | 955,055 | 1,951,893 | Feb 14, 2019 · 4:34 pm EST | Form 4 |
| Steven LoSVP Oncology | 585,416 | — | 585,416 | Nov 16, 2015 · 6:21 pm EST | Form 4 |
| Patrick G EnrightDirector | 272,281 | 114,675 | 386,956 | Mar 20, 2017 · 4:36 pm EDT | Form 4 |
| Bakker Juliet Tammenoms10% Owner | 133,539 | 215,282 | 348,821 | Dec 19, 2016 · 1:29 pm EST | Form 4 |
| James N WilsonDirector | 115,782 | 200,000 | 315,782 | Sep 16, 2026 · 4:30 pm EDT | Form 4 |
| Daniel BradburyDirector | — | 130,575 | 130,575 | Feb 12, 2019 · 9:44 pm EST | Form 4 |
| Anne M LeDouxVP & Controller | 50,000 | — | 50,000 | Sep 29, 2015 · 6:30 pm EDT | Form 4 |
| Gary Charles RobbChief Business Officer | 31,156 | 15,571 | 46,727 | Sep 18, 2026 · 7:47 pm EDT | Form 4 |
| David L MahoneyDirector | — | 26,147 | 26,147 | Aug 20, 2026 · 4:30 pm EDT | Form 4 |
| Sean MaduckSee Remarks | 9,938 | 10,000 | 19,938 | Sep 3, 2026 · 9:16 pm EDT | Form 4 |
| Atabak MokariChief Financial Officer | 16,304 | — | 16,304 | Sep 3, 2026 · 9:06 pm EDT | Form 4 |
| Renee D GalaDirector | 10,000 | — | 10,000 | Mar 7, 2018 · 8:38 pm EST | Form 4 |
| Joseph Douglas LyonSee Remarks | 5,683 | — | 5,683 | Sep 16, 2026 · 4:30 pm EDT | Form 4 |
| William GuyerChief Development Officer | 4,313 | — | 4,313 | Sep 3, 2026 · 9:16 pm EDT | Form 4 |
| Roberto Wandenkolk VieiraPresident, Oncology | 3,946 | — | 3,946 | Sep 18, 2026 · 7:53 pm EDT | Form 4 |
| Kimberly ParkDirector | 0 | — | 0 | Aug 28, 2026 · 4:30 pm EDT | Form 4 |
| Daniel N Swisher Jr.Director | 0 | — | 0 | Jun 22, 2015 · 8:26 pm EDT | Form 3 |
| Robert S FishmanChief Medical Officer | 0 | — | 0 | Nov 9, 2018 · 5:06 pm EST | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.